Industry News
Successful Phase 2b Study Results for GNbAC1 in Multiple Sclerosis
CHANGE-MS study confirms safety of GNbAC1 and reveals positive results related to neuroprotection in Multiple Sclerosis
CHANGE-MS study confirms safety of GNbAC1 and reveals positive results related to neuroprotection in Multiple Sclerosis